Matthew J. Carlyle
Direktor/Vorstandsmitglied bei Bright Angel Therapeutics, Inc.
Profil
Matthew J.
Carlyle is currently a Director at NEOMED-LABS, Inc., Bright Angel Therapeutics, Inc., and Neurasic Therapeutics, Inc. He is also a Partner at NDI Capital, Inc. since 2004.
In addition, he is a Member of CFA Institute and CFA Vancouver.
Previously, he worked as a Finance Director at Neuro Discovery, Inc. and as the Chief Financial Officer & Secretary at Allon Therapeutics, Inc. from 2001 to 2012.
Aktive Positionen von Matthew J. Carlyle
| Unternehmen | Position | Beginn |
|---|---|---|
CFA Institute
 CFA Institute Miscellaneous Commercial ServicesCommercial Services CFA Institute operates as non-profit organization, which engages in the provision of chartered financial analyst programs. It offers certificate in investment performance measurement program, investment foundations, and scholarship. The company was founded in 1965 and is headquartered in Charlottesville, VA. | Corporate Officer/Principal | - |
| CFA Vancouver | Corporate Officer/Principal | - |
NDI Capital, Inc.
 NDI Capital, Inc. Investment ManagersFinance NDI Capital, Inc (NDI Capital) is a venture capital firm Founded in 2003 and headquartered in Vancouver, British Columbia. | Private Equity Investor | 01.09.2004 |
Bright Angel Therapeutics, Inc.
 Bright Angel Therapeutics, Inc. BiotechnologyHealth Technology Bright Angel Therapeutics, Inc. is a pre-clinical stage biotechnology company. It is focused on the development of novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections. The company is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | - |
Neurasic Therapeutics, Inc.
 Neurasic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neurasic Therapeutics, Inc. develops opiate-sparing and pain-relieving drugs. The company was founded in June 2020 and is headquartered in Westmount, Canada. | Direktor/Vorstandsmitglied | - |
NEOMED-LABS, Inc.
 NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology NEOMED-LABS, Inc. engages in operation of a contract research organization. It offers clinical immunology laboratory services. The company was founded by Max Fehlmann in March 4, 2015 and is headquartered in Montréal, Canada. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Matthew J. Carlyle
| Unternehmen | Position | Ende |
|---|---|---|
| Neuro Discovery, Inc. | Finanzdirektor/CFO | - |
| ALLON THERAPEUTICS INC. | Finanzdirektor/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALLON THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
CFA Institute
CFA Institute Miscellaneous Commercial ServicesCommercial Services CFA Institute operates as non-profit organization, which engages in the provision of chartered financial analyst programs. It offers certificate in investment performance measurement program, investment foundations, and scholarship. The company was founded in 1965 and is headquartered in Charlottesville, VA. | Commercial Services |
| CFA Vancouver | |
| Neuro Discovery, Inc. | Commercial Services |
NDI Capital, Inc.
NDI Capital, Inc. Investment ManagersFinance NDI Capital, Inc (NDI Capital) is a venture capital firm Founded in 2003 and headquartered in Vancouver, British Columbia. | Finance |
Bright Angel Therapeutics, Inc.
Bright Angel Therapeutics, Inc. BiotechnologyHealth Technology Bright Angel Therapeutics, Inc. is a pre-clinical stage biotechnology company. It is focused on the development of novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections. The company is headquartered in Toronto, Canada. | Health Technology |
Neurasic Therapeutics, Inc.
Neurasic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neurasic Therapeutics, Inc. develops opiate-sparing and pain-relieving drugs. The company was founded in June 2020 and is headquartered in Westmount, Canada. | Health Technology |
NEOMED-LABS, Inc.
NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology NEOMED-LABS, Inc. engages in operation of a contract research organization. It offers clinical immunology laboratory services. The company was founded by Max Fehlmann in March 4, 2015 and is headquartered in Montréal, Canada. | Health Technology |
